MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 461007 | Name: Dicloxacillin sodium
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Dicloxacillin sodium is an oral semisynthetic isoxazolyl antistaphylococcal penicillin. Most active of the isoxazolyl antistaphylococcal penicillins. Stable against penicillinase and active against many of the penicillinase-producing strains of Staphylococcus aureus. Clinical uses include skin and soft-tissue, bone and joint, respiratory tract, and urinary tract infections.

Chemical Structure

Dicloxacillin sodium
CAS#13412-64-1 (sodium hydrate)

Theoretical Analysis

MedKoo Cat#: 461007

Name: Dicloxacillin sodium

CAS#: 13412-64-1 (sodium hydrate)

Chemical Formula: C19H18Cl2N3NaO6S

Exact Mass: 0.0000

Molecular Weight: 510.31

Elemental Analysis: C, 44.72; H, 3.56; Cl, 13.89; N, 8.23; Na, 4.50; O, 18.81; S, 6.28

Price and Availability

Size Price Availability Quantity
1g USD 300.00 2 weeks
5g USD 750.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
3116-76-5 (free acid) 13412-64-1 (sodium hydrate)
Synonym
Dicloxacillin sodium; BLP-1011; BRL-1702; P 1011; P-1011; P1011; MDI-PC; Sodium dicloxacillin hydrate; Sodium dicloxacillin monohydrate Dicloxacillin sodium hydrate; Dicloxacillin sodium salt hydrate; Dicloxacillin sodium monohydrate; Dichlorstapenor sodium
IUPAC/Chemical Name
sodium (2S,5R,6R)-6-(3-(2,6-dichlorophenyl)-5-methylisoxazole-4-carboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate hydrate
InChi Key
SIGZQNJITOWQEF-VICXVTCVSA-M
InChi Code
InChI=1S/C19H17Cl2N3O5S.Na.H2O/c1-7-10(12(23-29-7)11-8(20)5-4-6-9(11)21)15(25)22-13-16(26)24-14(18(27)28)19(2,3)30-17(13)24;;/h4-6,13-14,17H,1-3H3,(H,22,25)(H,27,28);;1H2/q;+1;/p-1/t13-,14+,17-;;/m1../s1
SMILES Code
O=C([C@@H](C(C)(C)S[C@]1([H])[C@@H]2NC(C3=C(C)ON=C3C4=C(Cl)C=CC=C4Cl)=O)N1C2=O)[O-].[H]O[H].[Na+]
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 510.31 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Naguib IA, Abdelaleem EA, Zaazaa HE, Hussein EA. Partial Least-Squares and Linear Support Vector Regression Chemometric Methods for Simultaneous Determination of Amoxicillin Trihydrate and Dicloxacillin Sodium in the Presence of Their Common Impurity. J AOAC Int. 2016 Jul;99(4):972-979. doi: 10.5740/jaoacint.16-0033. Epub 2016 Jun 15. PubMed PMID: 27305461. 2: Wu G, Zheng Y, Zhou H, Hu X, Liu J, Zhai Y, Zhu M, Wu L, Shentu J. Safety and pharmacokinetics of dicloxacillin in healthy Chinese volunteers following single and multiple oral doses. Drug Des Devel Ther. 2015 Oct 16;9:5687-95. doi: 10.2147/DDDT.S92117. eCollection 2015. PubMed PMID: 26527863; PubMed Central PMCID: PMC4621192. 3: Acharya DR, Patel DB. Development and Validation of RP-HPLC Method for Simultaneous Estimation of Cefpodoxime Proxetil and Dicloxacillin Sodium in Tablets. Indian J Pharm Sci. 2013 Jan;75(1):31-5. doi: 10.4103/0250-474X.113538. PubMed PMID: 23901158; PubMed Central PMCID: PMC3719147. 4: Dhoka MV, Sandage SJ, Dumbre SC. Simultaneous determination of cefixime trihydrate and dicloxacillin sodium in pharmaceutical dosage form by reversed-phase high-performance liquid chromatography. J AOAC Int. 2010 Mar-Apr;93(2):531-5. PubMed PMID: 20480900. 5: Tao JL, Zhan XC, Li LL, Lin B, Jiang L. Single time point isothermal drug stability experiments at constant humidity. Yakugaku Zasshi. 2009 Mar;129(3):341-5. PubMed PMID: 19252391. 6: Raj TJ, Bharati CH, Rao KR, Rao PS, Narayan GK, Parikh K. Identification and characterization of degradation products of dicloxacillin in bulk drug and pharmaceutical dosage forms. J Pharm Biomed Anal. 2007 Mar 12;43(4):1470-5. Epub 2006 Nov 27. PubMed PMID: 17125952. 7: Jensen AG, Wachmann CH, Espersen F, Scheibel J, Skinhøj P, Frimodt-Møller N. Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases. Arch Intern Med. 2002 Jan 14;162(1):25-32. PubMed PMID: 11784216. 8: Dimitrova DJ. Pharmacokinetic study of dicloxacillin sodium following intravenous and intramuscular administration to pigs. J Vet Pharmacol Ther. 2000 Apr;23(2):99-101. PubMed PMID: 10849254. 9: Dimitrova DJ. Pharmacokinetics of dicloxacillin sodium following intravenous and intramuscular administration to domestic cats. J Vet Pharmacol Ther. 1996 Oct;19(5):405-7. PubMed PMID: 8905577. 10: Morelli B. Second-derivative spectrophotometric assay of mixtures of dicloxacillin sodium and ampicillin sodium in pharmaceuticals. J Pharm Sci. 1988 Dec;77(12):1042-6. PubMed PMID: 3244108. 11: Krstenansky PM, Jones WN, Garewal HS. Effect of dicloxacillin sodium on the hypoprothrombinemic response to warfarin sodium. Clin Pharm. 1987 Oct;6(10):804-6. PubMed PMID: 3505843. 12: Ofner CM 3rd, Schott H. Swelling studies of gelatin. II: Effect of additives. J Pharm Sci. 1987 Sep;76(9):715-23. PubMed PMID: 11002809. 13: Sylvestri MF, Makoid MC, Adams SC. Stability of dicloxacillin sodium oral suspension stored in polypropylene syringes. Am J Hosp Pharm. 1987 Jun;44(6):1401-5. PubMed PMID: 3618620. 14: Kleinman MS, Presberg JE. Cholestatic hepatitis after dicloxacillin-sodium therapy. J Clin Gastroenterol. 1986 Feb;8(1):77-8. PubMed PMID: 3701014. 15: Disney FA, Pichichero ME. Treatment of Staphylococcus aureus infections in children in office practice. Am J Dis Child. 1983 Apr;137(4):361-4. PubMed PMID: 6600877. 16: Fujita K, Iseki K, Yoshioka H, Sasaki T, Ando T, Nakamura M. Bacteriology of acute otitis media in Japanese children. Am J Dis Child. 1983 Feb;137(2):152-4. PubMed PMID: 6336890. 17: Yogev R. Soft-tissue infections of ampicillin-resistant Haemophilus influenzae type b. The use of ampicillin and nafcillin in their treatment. Am J Dis Child. 1981 May;135(5):410-2. PubMed PMID: 6972160. 18: Steele RW. Recurrent staphylococcal infection in families. Arch Dermatol. 1980 Feb;116(2):189-90. PubMed PMID: 7356349. 19: Szczygiel B, Switka S, Wencel J, Pertkiewicz M, Ruciński J, Schaeffer A, Zdziarska H. [Sensitivity of Staphylococcus aureus strains to dicloxacillin Polfa and serum concentrations of dicloxacillin sodium following oral administration]. Pol Tyg Lek. 1975 Dec 29;30(52):2189-91. Polish. PubMed PMID: 1042979.